Overview
PT-141 (Bremelanotide) Overview
PT-141, also called bremelanotide, is a synthetic cyclic heptapeptide and a structural analog of alpha-melanocyte-stimulating hormone (α-MSH). It is a metabolite of the melanocortin analog Melanotan II. The ring is closed through a lactam bridge between the aspartic acid and lysine residues, which gives the molecule a constrained conformation and greater resistance to enzymatic breakdown than its linear counterparts.
In laboratory work, PT-141 is used as a tool for melanocortin receptor studies. It shows affinity for melanocortin receptor subtypes 3 and 4 (MC3R and MC4R), with limited activity at MC1R, MC2R, and MC5R. That selectivity, combined with its small size, makes it a common reference compound in in vitro receptor binding assays and preclinical central signaling models, where investigators compare central melanocortin pathway activity against peripherally mediated mechanisms such as PDE5 or nitric oxide signaling.
Reported preclinical and in vitro work has examined receptor binding kinetics, MC4R-linked signal transduction in cultured cell lines, hypothalamic neuronal activation markers, and interactions with dopaminergic and serotonergic signaling pathways. All findings described here come from in vitro or preclinical laboratory models.
Each lot is made by solid-phase peptide synthesis, third-party tested, and supplied with a Certificate of Analysis.
| Sequence | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH |
|---|---|
| Sequence length | 7 amino acids (cyclic heptapeptide) |
| Also known as | Bremelanotide, PT-141, PT141 |
| Molecular formula | C50H68N14O10 |
| Molecular weight | 1025.2 g/mol |
| CAS number | 189691-06-3 |
| PubChem CID | 9941379 |
| Form | Lyophilized powder |
| Purity | ≥99% by HPLC, per COA |
| Storage | -20°C, sealed and protected from light |
Certificate of Analysis
| Date | Lot | Certificate |
|---|---|---|
| PT-141 - 10mgJun 11, 2026 | 260519PT103 | View COA |